The Kaleido Revolution

The human microbiome—the beneficial microbial communities that live on all human body surfaces—is one of the most important frontiers in modern medicine. It plays a central role in numerous severe metabolic, inflammatory, and infectious diseases.

Kaleido Biosciences is a clinical-stage biotechnology company that is developing the first therapeutic products to systematically shape the microbiome. We have discovered a broad new means of driving the central functions of the human microbiome with applications spanning a wide range of important diseases. A revolution in medicine is coming.